Page last updated: 2024-08-21

testolactone and Fibrous Dysplasia, Polyostotic

testolactone has been researched along with Fibrous Dysplasia, Polyostotic in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19903 (37.50)18.7374
1990's5 (62.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feuillan, PP2
Cutler, GB; Feuillan, PP; Jones, J1
Cutler, GB; Feuillan, P; Leschek, EW; Merke, D1
Cutler, GB; Feuillan, PP; Jones, J; Manasco, PK; Oerter, KE1
Hauffa, BP; Havers, W; Stolecke, H1
Barnes, K; Cutler, GB; Dwyer, A; Feuillan, PP; Foster, CM; Hench, KD; Loriaux, DL; Malley, JD; Pescovitz, OH; Shawker, T1
Barnes, KM; Cassorla, FG; Comite, F; Cutler, GB; Feuillan, PP; Foster, CM; Kenigsberg, D; Laue, L; Pescovitz, OH; Ross, JL1

Reviews

3 review(s) available for testolactone and Fibrous Dysplasia, Polyostotic

ArticleYear
McCune-Albright syndrome.
    Current therapy in endocrinology and metabolism, 1997, Volume: 6

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Female; Fibrous Dysplasia, Polyostotic; Humans; Male; Puberty, Precocious; Testolactone

1997
Use of aromatase inhibitors in precocious puberty.
    Endocrine-related cancer, 1999, Volume: 6, Issue:2

    Topics: Adrenal Hyperplasia, Congenital; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Enzyme Inhibitors; Estrogens; Female; Fibrous Dysplasia, Polyostotic; Humans; Male; Puberty, Precocious; Testolactone

1999
Pubertal growth: physiology and pathophysiology.
    Recent progress in hormone research, 1986, Volume: 42

    Topics: Aging; Body Height; Dose-Response Relationship, Drug; Estradiol; Female; Fibrous Dysplasia, Polyostotic; Gonadotropin-Releasing Hormone; Gonadotropins; Growth; Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Puberty; Puberty, Delayed; Puberty, Precocious; Sex Characteristics; Testolactone; Thyroid Hormones; Turner Syndrome; Ulna

1986

Other Studies

5 other study(ies) available for testolactone and Fibrous Dysplasia, Polyostotic

ArticleYear
McCune-Albright syndrome.
    Current therapy in endocrinology and metabolism, 1994, Volume: 5

    Topics: Adolescent; Calcitriol; Diagnosis, Differential; Female; Fibrous Dysplasia, Polyostotic; Humans; Ketoconazole; Leuprolide; Male; Medroxyprogesterone Acetate; Octreotide; Ovariectomy; Propylthiouracil; Puberty, Precocious; Spironolactone; Testolactone; Thyroid Diseases

1994
Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome.
    The Journal of clinical endocrinology and metabolism, 1993, Volume: 77, Issue:3

    Topics: Age Determination by Skeleton; Androstenedione; Body Height; Bone Development; Child; Child, Preschool; Estradiol; Female; Fibrous Dysplasia, Polyostotic; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menstruation; Puberty; Puberty, Precocious; Testolactone; Testosterone

1993
Luteinizing hormone-releasing hormone (LHRH)-independent precocious puberty unresponsive to LHRH agonist therapy in two girls lacking features of the McCune-Albright syndrome.
    The Journal of clinical endocrinology and metabolism, 1991, Volume: 73, Issue:6

    Topics: Child Development; Child, Preschool; Drug Resistance; Female; Fibrous Dysplasia, Polyostotic; Gonadotropin-Releasing Hormone; Humans; Puberty, Precocious; Testolactone

1991
Short-term effects of testolactone compared to other treatment modalities on longitudinal growth and ovarian activity in a girl with McCune-Albright syndrome.
    Helvetica paediatrica acta, 1987, Volume: 42, Issue:5-6

    Topics: Androgen Antagonists; Body Height; Bone Development; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Female; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Follow-Up Studies; Humans; Infant; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Cysts; Ovarian Function Tests; Spironolactone; Testolactone

1987
Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone.
    The New England journal of medicine, 1986, Oct-30, Volume: 315, Issue:18

    Topics: Aromatase Inhibitors; Bone Development; Child, Preschool; Estradiol; Estrone; Female; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Follicle Stimulating Hormone; Growth; Humans; Infant; Luteinizing Hormone; Menstruation; Ovary; Puberty, Precocious; Sexual Maturation; Testolactone

1986